Journal of Zhejiang University-SCIENCE B

, Volume 20, Issue 10, pp 793–802 | Cite as

Changes in peripheral blood inflammatory factors (TNF-α and IL-6) and intestinal flora in AIDS and HIV-positive individuals

  • Jing Lu
  • Sai-sai Ma
  • Wei-Ying Zhang
  • Jian-ping DuanEmail author



In this study, we investigated the changes in peripheral blood inflammatory factors and intestinal flora in acquired immune deficiency syndrome (AIDS) and human immunodeficiency virus (HIV)-positive individuals (AIDS/HIV patients), and explored the relationships among intestinal flora, peripheral blood inflammatory factors, and CD4+ T lymphocytes.


Thirty blood and stool samples from an AIDS group and a control group were collected. The levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were determined by enzyme-linked immunosorbent assay (ELISA), and the number of CD4+ T lymphocytes by a FACSCount automated instrument. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to determine the messenger RNA (mRNA) levels of Bifidobacterium, Lactobacillus, Escherichia coli, Enterococcus faecalis, and Enterococcus faecium. Correlations among intestinal flora, inflammatory factor levels, and CD4+ T lymphocyte values were evaluated using the Spearman correlation coefficient.


The levels of TNF-α and IL-6 in the AIDS group were higher than those in the control group, while the number of CD4+ T lymphocytes was lower. The amounts of Bifidobacterium and Lactobacillus in the AIDS group were significantly lower than those in control group, while the amounts of E. coli, E. faecalis, and E. faecium were much higher. The amounts of Bifidobacterium and Lactobacillus were negatively correlated with the content of TNF-α and IL-6 and the CD4+ T lymphocyte count, while those correlations were reversed for E. coli, E. faecalis, and E. faecium.


The intestinal microbiota of AIDS/HIV patients were disordered, and there was a correlation between the amount of intestinal flora and the number of CD4+ T lymphocytes and the levels of TNF-α and IL-6.


Acquired immune deficiency syndrome (AIDS) Tumor necrosis factor-α (TNF-α) Interleukin-6 (IL-6) Intestinal flora CD4+ T lymphocytes 

AIDS 和 HIV 阳性个体外周血炎症因子 (TNF-α 和 IL-6) 和肠道菌群的变化研究


目 的

本研究探究获得性免疫缺陷综合征 (AIDS) 和人类免疫缺陷病毒 (HIV) 阳性个体患者外周血炎症因子和肠道菌群的变化, 同时探讨了肠道菌群、 外周血炎症因子和CD4+ T 淋巴细胞之间的关系。


首次探讨了 AIDS 和 HIV 阳性个体患者中肠道菌群、 外周血炎症因子和 CD4+ T 淋巴细胞之间的关系。

方 法

从艾滋病组和对照组分别收集 30 份血液和粪便样本。 使用酶联免疫吸附测定 (ELISA) 法测定肿瘤坏死因子 (TNF-α) 和白细胞介素-6 (IL-6) 的水平; 用流式细胞仪测定 CD4+ T 淋巴细胞数目; 采用实时定量聚合酶链式反应 (qRT-PCR) 法检测双歧杆菌、 乳酸菌、 大肠杆菌、 粪肠球菌和屎肠球菌的 mRNA 水平; 采用 Spearman 分析肠道菌群、 炎症因子与 CD4+ T 淋巴细胞之间的相关性。

结 论

不但 AIDS/HIV 患者体内肠道菌群紊乱, 而且肠道菌群数量与 CD4+ T 淋巴细胞数量以及T NF-α、 IL-6 水平存在相关性。


获得性免疫缺陷综合征 肿瘤坏死因子 (TNF-α) 白细胞介素-6 (IL-6) 肠道菌群 CD4+ T 淋巴细胞 

CLC number



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



Jing LU and Sai-sai MA: conception and design of this study, and analysis of data. Wei-ying ZHANG and Jian-ping DUAN: revising the article critically for important intellectual content. All authors have read and approved the final manuscript. Therefore, all authors have full access to all the data in the study and take responsibility for the integrity and security of the data.

Compliance with ethics guidelines

Jing LU, Sai-sai MA, Wei-ying ZHANG, and Jian-ping DUAN declare that they have no conflict of interest.

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study.


  1. Bäckhed F, Fraser CM, Ringel Y, et al., 2012. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe, 12%(5):611–622. CrossRefGoogle Scholar
  2. Brenchley JM, 2013. Mucosal immunity in human and simian immunodeficiency lentivirus infections. Mucosal Immunol, 6%(4):657–665. CrossRefGoogle Scholar
  3. Capeau J, 2011. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Clin Infect Dis, 53%(11):1127–1129. CrossRefGoogle Scholar
  4. de Medeiros RM, Valverde-Villegas JM, Junqueira DM, et al., 2016. Rapid and slow progressors show increased IL-6 and IL-10 levels in the pre-AIDS stage of HIV infection. PLoS ONE, 11(5):e0156163. Google Scholar
  5. de Pablo-Bernal RS, Ruiz-Mateos E, Rosado I, et al., 2014. TNF-α levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjects. J Antimicrob Chemother, 69%(11):3041–3046. CrossRefGoogle Scholar
  6. Dillon SM, Lee EJ, Kotter CV, et al., 2014. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol, 7%(4):983–994. CrossRefGoogle Scholar
  7. Dinh DM, Volpe GE, Duffalo C, et al., 2015. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J Infect Dis, 211%(1):19–27. CrossRefGoogle Scholar
  8. Fragoso JM, Vargas Alarcón G, Jiménez Morales S, et al., 2014. Tumor necrosis factor alpha (TNF-α) in autoimmune diseases (AIDs): molecular biology and genetics. Gac Méd Méx, 150%(4):334–344 (in Spanish).Google Scholar
  9. Gedle D, Kumera G, Eshete T, et al., 2017. Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDs patients on HAART in Butajira, Ethiopia. J Health Popul Nutr, 36:15. Google Scholar
  10. He YW, Cai WP, Cen YW, et al., 2014. A preliminary study on intestinal microflora of AIDS patients and its correlation with CD4+ T lymphocytes. Guangdong Med J, 35%(14):2172–2174 (in Chinese). Google Scholar
  11. Hirano T, Kishimoto T, 1989. Interleukin-6: possible implications in human diseases. Res Clin Lab, 19%(1):1–10. Google Scholar
  12. Irvine SL, Hummelen R, Hekmat S, et al., 2010. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDs. J Clin Gastroenterol, 44(9):e201-e205. Google Scholar
  13. Klase Z, Ortiz A, Deleage C, et al., 2015. Dysbiotic bacteria translocate in progressive SIV infection. Mucosal Immunol, 8%(5):1009–1020. CrossRefGoogle Scholar
  14. Klatt NR, Villinger F, Bostik P, et al., 2008. Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J Clin Invest, 118%(6):2039–2049. Google Scholar
  15. Kolgiri V, Patil VW, 2017. Protein carbonyl content: a novel biomarker for aging in HIV/AIDs patients. Braz J Infect Dis, 21%(1):35–41. CrossRefGoogle Scholar
  16. Lei Y, Wang KH, Gong KM, et al., 2012. Real-time fluorescence quantitative PCR analysis of intestinal flora in patients with acquired immune deficiency syndrome. J Pract Med, 28%(1):69–71 (in Chinese). Google Scholar
  17. Li L, Zhong Q, 2017. Correlation of intestinal microflora with cytokines and Toll-like receptors expression in patients with ulcerative colitis. Infect Dis Inf, 30%(6):361–364 (in Chinese). Google Scholar
  18. Lu W, Feng YQ, Jing FH, et al., 2018. Association between gut microbiota and CD4 recovery in HIV-1 infected patients. Front Microbiol, 9:1451. CrossRefGoogle Scholar
  19. Lyte M, 2013. Microbial endocrinology in the microbiomegut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog, 9(11): e1003726. Google Scholar
  20. Maartens G, Celum C, Lewin SR, 2014. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet, 384%(9939):258–271. CrossRefGoogle Scholar
  21. Márquez M, del Álamo CFG, Girón-González JA, 2016. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: influence on innate and acquired immunity. World J Gastroenterol, 22%(4):1433–1448. CrossRefGoogle Scholar
  22. Monachese M, Cunningham-Rundles S, Diaz MA, et al., 2011. Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report. Gut Microbes, 2%(3):198–207. CrossRefGoogle Scholar
  23. Monaco CL, Gootenberg DB, Zhao GY, et al., 2016. Altered virome and bacterial microbiome in human immunodeficiency virus-associated acquired immunodeficiency syndrome. Cell Host Microbe, 19%(3):311–322. CrossRefGoogle Scholar
  24. O’Shea JJ, Paul WE, 2010. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science, 327%(5969):1098–1102. CrossRefGoogle Scholar
  25. Ponte R, Mehraj V, Ghali P, et al., 2016. Reversing gut damage in HIV infection: using non-human primate models to instruct clinical research. EBioMedicine, 4:40–49. CrossRefGoogle Scholar
  26. Quiloan MLG, Vu J, Carvalho J, 2012. Enterococcus faecalis can be distinguished from Enterococcus faecium via differential susceptibility to antibiotics and growth and fermentation characteristics on mannitol salt agar. Front Biol, 7%(2):167–177. CrossRefGoogle Scholar
  27. Ren FN, 2018. Analysis on the influence of traditional Chinese medicine comprehensive intervention on AIDS/HIV patients. Guangming J Chin Med, 33%(11):1585–1587 (in Chinese). Google Scholar
  28. Rosado-Sánchez I, Jarrín I, Pozo-Balado MM, et al., 2017. Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recovery. Antiviral Res, 142:76-82. Google Scholar
  29. Routy B, le Chatelier E, Derosa L, et al., 2018. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, 359%(6371):91–97. CrossRefGoogle Scholar
  30. Shah S, Kongre V, Kumar V, et al., 2016. A study of parasitic and bacterial pathogens associated with diarrhea in HIVpositive patients. Cureus, 8(9):e807. Google Scholar
  31. Sobti RC, Berhane N, Mahedi SA, et al., 2010. Polymorphisms of IL-6 174 G/C, IL-10-592 C/A and risk of HIV/AIDS among North Indian population. Mol Cell Biochem, 337(1–2):145–152. CrossRefGoogle Scholar
  32. Taiwo BO, Li X, Palella F, et al., 2009. Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART. HIV Med, 10%(10):657–660. CrossRefGoogle Scholar
  33. Utay NS, Hunt PW, 2016. Role of immune activation in progression to AIDS. Curr Opin HIV AIDS, 11%(2):131–137. CrossRefGoogle Scholar
  34. Vujkovic-Cvijin I, Dunham RM, Iwai S, et al., 2013. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med, 5(193):193ra91. CrossRefGoogle Scholar
  35. Wang ZQ, Orlikowsky T, Dudhane A, et al., 1994. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients. Eur J Immunol, 24%(7):1553–1557. CrossRefGoogle Scholar
  36. Yao F, Lu YQ, Jiang JK, et al., 2017. Immune recovery after fluid resuscitation in rats with severe hemorrhagic shock. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 18%(5):402–409. CrossRefGoogle Scholar
  37. Zhang J, Liu H, Wei B, 2017. Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 18%(4):277–288. CrossRefGoogle Scholar
  38. Zhang SG, Song YX, Shu XM, et al., 2017. A simple method for removing low-density granulocytes to purify T lymphocytes from peripheral blood mononuclear cells. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 18%(7):605–614. CrossRefGoogle Scholar

Copyright information

© Zhejiang University and Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Infectious DiseaseQingdao Sixth People’s HospitalQingdaoChina

Personalised recommendations